Ankur Drugs & Pharma (ANKURDR) is engaged in manufacturing pharma formulations in various dosage forms for leading Indian companies. Incorporated as Mridol Pharmaceuticals on Feb. 9, 1995, it got its present name on Apr. 30, 1999. The company manufactures tablets, capsules, liquid orals, dry syrups, injectables, effervescent tablets and powders, water for injection, eye and ear drops and ointments. Two manufacturing plants are located at Baddi in Himachal Pradesh and one in the Union Territory of Daman with installed capacities of 1,440 million tablets, 270 million capsules, 12 million dry syrup bottles and 24 million liquid syrup bottles. In FY07, it started implementing its strategic plan to set up a network of dedicated units for contract manufacturing of pharma products for multinational companies. Some of the clients include Ranbaxy Laboratories, Cipla, Khandelwal Laboratories, Makers Laboratories, Hetero Healthcare, Elder Pharma, Lyka Labs, Blue Cross Laboratories, Cadila Laboratories, Wockhardt, Glenmark Pharma, Parentral Drugs (India), Torrent Pharmaceuticals, Sandoz (India), Shreya Life Sciences, Synthiko Formulations, and Nicholas Piramal India. The registered office is located at C-306, Crystal Plaza, Andheri Link Road, Andheri (W), Mumbai-400053. Financials The company announced fall of 171.39% in standalone net profit on y-o-y basis to Rs 200.89 million, while total income declined 42.34% y-o-y basis to Rs 1.50 billion for the quarter ended December 2010.
You
should Trade Less But Trade Accurately & this is Achieved with our Tip.
